sec filings
Insiders
Open-market buys and sales that company insiders report to the SEC on .
Side
Planned sales
Role
BBTX
Updated Nov 3, 2026, 9:02 AM ET
| Stock | Side | Value | Insider | Shares | Avg price | Filed | Filing |
|---|---|---|---|---|---|---|---|
| BBTX Bambusa Therapeutics, Inc. | Buy | $6.00M$6,000,000 | Salvia Investment GmbH · 10% owner 10% owner | 375,000 sh+4.2% stake | · at $16.00 | · Nov 2Nov 2, 4:07 PM ET | · Filing |
| BBTX Bambusa Therapeutics, Inc. | Buy | $6.00M$6,000,000 | Jeggle Helmut Wolfgang · Director, 10% owner Director, 10% owner | 375,000 sh | · at $16.00 | · Nov 2Nov 2, 4:06 PM ET | · Filing |